ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 694456 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 694456; 2) Community: the network communities that were significantly associated with the response to NSC 694456; 3) Molecule: the relationships between components within communities and NSC 694456; 4) MDR: the compounds that were significantly associated with the NSC 694456.

NSC Compound Enrichment Correlation
NSC 742554 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, 0.0126882509540132 0.15357635
NSC 747459 Null 0.0126882509540132 0.21257871
NSC 748382 Null 0.0126882509540132 0.20050127
NSC 756407 GW853606X 0.0126882509540132 0.21500192
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0126882509540132 0.17190291
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0126882509540132 0.02586088
NSC 8985 WLN: 1R D-I-R D1 &E &6/14 0.0126882509540132 0.15134571
NSC 100880 Camptothecin 0.0126882509540134 0.51820608
NSC 105014 Cladribine 0.0126882509540134 0.24544628
NSC 114346 Null 0.0126882509540134 0.34913052
Total:116  Current:32    [First] [Prev] [Next] [Last]